Pharmaceutical preparations and substances for the treatment of inflammatory skin conditions; veterinary and sanitary preparations and substances for the treatment of inflammatory skin conditions; chemical preparations for pharmaceutical purposes, namely, for the treatment of inflammation of the skin, pain and psoriasis; topical preparations, namely, liquids, gels, creams, lotions and sprays for the treatment of inflammation and pain; pharmaceutical preparations in the form of vesicles for the treatment of pain and inflammatory skin conditions; parenteral preparations, namely, sterile preparations in the form of vesicles for injection, infusion or implantation into the human body for the treatment of inflammatory skin conditions; chemical preparations in the form of vesicles, namely, liquids, gels, creams, lotions and sprays for the treatment of pain and inflammatory skin conditions for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammatory skin conditions; dispersions and dry preparations of liposomal active substance carriers for use as a pharmaceutical, cosmetic substance carrier, in the nature of a liquid, gel, cream, lotion or lipid; pharmaceutical cosmetic and veterinary substances for the treatment of pain and inflammatory skin conditions; pharmaceuticals for medical use for the treatment of pain and inflammatory skin conditions; topical and parenteral pharmaceutical lipids for the treatment of pain and inflammatory skin conditions; cosmeceutical preparations in the nature of medicated cosmetics; local anesthetics; topical cream for treating inflammatory skin conditions; medicated topical dispersions, medicated topical lotions, medicated topical ointments, medicated topical gels, medicated topical sprays, medicated topical lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain and inflammatory skin conditions; surfactants for medical use in the treatment of diseases affecting the immune system, inflammatory diseases, diseases of the skin, hair and ear, treatment of inflammation, atopic eczema, dishydrotic hand eczema, plaque-type psoriasis, seborrhoeic eczema, acne vulgaris, pain or fungal infection, and disorders related to the skin

Medical devices in the nature of a carrier with nanostructures which cross through the skin for the treatment of dermal conditions associated with deep layers of the skin beneath the epidermis; molecular filtering devices for medical use, namely, a gel, liquid or cream preparation as a drug delivery device which filters through the skin and has a physical therapeutic effect at the point of complaint; medical, veterinary and surgical devices, namely, a medical device which acts as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin, which is used to reduce irritation, swelling or inflammation and target the symptoms of inflammatory skin conditions; inhalers for medical purposes sold empty; injection devices, namely, medical fluid injectors and medical syringes; medical instruments and devices for the administration of skin disease therapy and prophylaxis preparations and substances